These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 2504659)

  • 1. Fibroblast-specific common fragile sites induced by aphidicolin.
    Murano I; Kuwano A; Kajii T
    Hum Genet; 1989 Aug; 83(1):45-8. PubMed ID: 2504659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA polymerase alpha inhibition by aphidicolin induces gaps and breaks at common fragile sites in human chromosomes.
    Glover TW; Berger C; Coyle J; Echo B
    Hum Genet; 1984; 67(2):136-42. PubMed ID: 6430783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population cytogenetics of aphidicolin-induced fragile sites.
    Tedeschi B; Vernole P; Sanna ML; Nicoletti B
    Hum Genet; 1992 Jul; 89(5):543-7. PubMed ID: 1634231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell type-dependent difference in the distribution and frequency of excess thymidine-induced common fragile sites: T lymphocytes and skin fibroblasts.
    Kuwano A; Murano I; Kajii T
    Hum Genet; 1990 May; 84(6):527-31. PubMed ID: 2338337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fragile sites induced by FUdR, caffeine, and aphidicolin. Their frequency, distribution, and analysis.
    Rao PN; Heerema NA; Palmer CG
    Hum Genet; 1988 Jan; 78(1):21-6. PubMed ID: 2962925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell type-dependent difference in the distribution and frequency of aphidicolin-induced fragile sites: T and B lymphocytes and bone marrow cells.
    Murano I; Kuwano A; Kajii T
    Hum Genet; 1989 Dec; 84(1):71-4. PubMed ID: 2514134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic effect of aphidicolin and ethanol on the induction of common fragile sites.
    Kuwano A; Kajii T
    Hum Genet; 1987 Jan; 75(1):75-8. PubMed ID: 3100418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of aphidicolin, FUdR and caffeine-induced fragile sites in lymphocytes of healthy Turkish individuals.
    Güven GS; Hacihanefioğlu S; Cenani A
    Genetica; 1999; 105(1):109-16. PubMed ID: 10483096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Common fragile sites in chromosomes of bone marrow cells and peripheral blood lymphocytes from healthy persons and leukemia patients.
    Furuya T; Ochi H; Watanabe S
    Cancer Genet Cytogenet; 1989 Nov; 43(1):131-8. PubMed ID: 2790768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Common fragile sites: their prevalence in subjects with constitutional and acquired chromosomal instability.
    Tedeschi B; Porfirio B; Vernole P; Caporossi D; Dallapiccola B; Nicoletti B
    Am J Med Genet; 1987 Jun; 27(2):471-82. PubMed ID: 3111262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Constitutive fragile sites in fra(X) individuals.
    Jenkins EC; Lele KP; Krawczun MS; Gross AC; Duncan CJ; Brown WT
    Am J Med Genet; 1988; 30(1-2):429-34. PubMed ID: 3052066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The expression of common fragile sites in peripheral blood lymphocytes of breast and colorectal cancer patients with aphidicolin.
    Balci A; Ekmekci A; Cetin R
    Tohoku J Exp Med; 1999 Oct; 189(2):107-16. PubMed ID: 10775054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Constitutive fragile sites 1p31, 3p14, 6q26, and 16q23 and their use as controls for false-negative results with the fragile(X).
    Daniel A; Ekblom L; Phillips S
    Am J Med Genet; 1984 Jul; 18(3):483-91. PubMed ID: 6476008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel putative fragile sites observed in feline fibroblasts treated with aphidicolin and fluorodeoxyuridine.
    Kubo K; Matsuyama S; Sato K; Shiomi A; Ono K; Ito Y; Ohashi F; Takamori Y
    J Vet Med Sci; 1998 Jul; 60(7):809-13. PubMed ID: 9713808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variation in the expression of aphidicolin-induced fragile sites in human lymphocyte cultures.
    Craig-Holmes AP; Strong LC; Goodacre A; Pathak S
    Hum Genet; 1987 Jun; 76(2):134-7. PubMed ID: 3111974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The expression of fragile sites in lymphocytes of patients with rectum cancer and their first-degree relatives.
    Tunca B; Egeli U; Zorluoğlu A; Yilmazlar T; Yerci O; Kizil A
    Cancer Lett; 2000 May; 152(2):201-9. PubMed ID: 10773413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced expression of aphidicolin-induced common fragile sites in peripheral lymphocyte chromosomes of patients with B-cell chronic lymphocytic leukemia.
    Nayak BN; Ray M
    Cancer Genet Cytogenet; 1989 May; 39(1):99-102. PubMed ID: 2499414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chromosomal fragile site expression in dogs: I. Breed specific differences.
    Stone DM; Jacky PB; Hancock DD; Prieur DJ
    Am J Med Genet; 1991 Aug; 40(2):214-22. PubMed ID: 1910263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on three rare fragile sites. 2q13, 12q13, and 17p12 segregating in one family.
    Romain DR; Columbano-Green LM; Smythe RH; Parfitt RG; Gebbie OB; Chapman CJ
    Hum Genet; 1986 Jun; 73(2):164-70. PubMed ID: 3087860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Common fragile sites and human cancer. A study on lymphocytes from neuroblastoma patients.
    Vernole P; Tedeschi B; Caporossi D; Nicoletti B
    Cancer Genet Cytogenet; 1988 Nov; 36(1):13-23. PubMed ID: 3144430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.